Kezar Life Sciences Inc. (KZR)
6.26
0.05 (0.81%)
At close: Jan 15, 2025, 1:23 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| PE Ratio | -6.74 | -72.61 | -165.57 | -58.91 | -24.27 | -104.56 | -271.36 | -257.08 |
| PS Ratio | 98.15 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 3.66 | 17.57 | 44.81 | 16.29 | 9.81 | 22.27 | -89.97 | -132.61 |
| P/FCF Ratio | -8.23 | -78.49 | -206.33 | -61.84 | -25.1 | -110.55 | -271.96 | -233.64 |
| P/OCF Ratio | -8.42 | -80.6 | -207.87 | -62.17 | -25.61 | -116.51 | -285.01 | -236.8 |
| OCF/S Ratio | -11.66 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.10 | 0.08 | 0.07 | 0.04 | 0.08 | n/a | n/a | n/a |
| Quick Ratio | 11.66 | 25.98 | 25.47 | 22.17 | 13.31 | 32.91 | 35.26 | 16.11 |
| Current Ratio | 11.66 | 25.98 | 25.77 | 22.48 | 13.52 | 32.91 | 35.26 | 16.11 |
| Asset Turnover | 0.03 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | -67.89 | -60.05 | -343.77 | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.54 | -0.24 | -0.27 | -0.28 | -0.4 | -0.21 | 0.33 | 0.52 |
| Return on Assets (ROA) | -0.46 | -0.22 | -0.24 | -0.26 | -0.35 | -0.2 | -0.16 | -0.79 |
| Return on Capital (ROIC) | -0.52 | -0.25 | -0.26 | -0.3 | -0.45 | -0.22 | -0.17 | -0.83 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 84.77% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -1.46K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -1.46K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -1.50K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | -1.19K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | -1.42K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |